The role of minimal access surgery for metastasectomy and cytoreduction.
This article summarizes findings about the applicability of minimal-access techniques for thoracic and upper gastrointestinal cancers, including those affecting the lung, liver, stomach, and adrenal gland. If metastasectomy and cytoreductive surgery are rapidly evolving, minimal-access surgery in this setting is in its introductory stages. Nevertheless, minimal-access metastasectomy and cytoreductive surgery harbor great potential for selected patients, but further clinical studies are needed.
Asbun
Horacio J
HJ
John Muir Health, 401 Gregory Lane, # 204, Walnut Creek, CA 94523, USA. asbun@bayareasurgical.net
Straznicka
Michaela
M
Strong
Vivian E
VE
D000310:Adrenal Gland Neoplasms / Q000556:secondary / Q000601:surgery*; D015179:Colorectal Neoplasms / Q000473:pathology*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery*; D008175:Lung Neoplasms / Q000556:secondary / Q000601:surgery*; D019060:Minimally Invasive Surgical Procedures / Q000379:methods*; D013274:Stomach Neoplasms / Q000601:surgery*